Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Pre-Treatment Period	STARTED	Lenalidomide Plus R-CHOP (R2-CHOP)	285
Pre-Treatment Period	STARTED	Placebo Plus R-CHOP	285
Pre-Treatment Period	COMPLETED	Lenalidomide Plus R-CHOP (R2-CHOP)	284
Pre-Treatment Period	COMPLETED	Placebo Plus R-CHOP	283
Pre-Treatment Period	NOT COMPLETED	Lenalidomide Plus R-CHOP (R2-CHOP)	1
Pre-Treatment Period	NOT COMPLETED	Placebo Plus R-CHOP	2
Treatment Period	STARTED	Lenalidomide Plus R-CHOP (R2-CHOP)	283
Treatment Period	STARTED	Placebo Plus R-CHOP	284
Treatment Period	COMPLETED	Lenalidomide Plus R-CHOP (R2-CHOP)	211
Treatment Period	COMPLETED	Placebo Plus R-CHOP	240
Treatment Period	NOT COMPLETED	Lenalidomide Plus R-CHOP (R2-CHOP)	72
Treatment Period	NOT COMPLETED	Placebo Plus R-CHOP	44

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02285062/flow